By: Ashleigh Furlong, Marthe Fourcade
Boehringer Ingelheim GmbH’s and Zealand Pharma A/S’s experimental obesity drug survodutide helped patients with diabetes shed as much as 13.1% of their weight, disappointing investors.
Ashleigh Furlong is a health care reporter at Bloomberg. She covers a range of topics within the healthcare sector, including pharmaceuticals, public health, and healthcare technology, with a focus on patient care and digital health innovations. Ashleigh's work has been featured in prominent publications such as Yahoo Finance, Scientific American, and Fortune.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Ashleigh Furlong's coverage spans a variety of topics, with a significant focus on healthcare and pharmaceutical issues. She places particular emphasis on government announcements, legal policy regulation, and breaking news.
Given her extensive coverage of healthcare and pharmaceutical matters, she may be interested in receiving pitches related to these areas. For instance, providing insights into recent health crises or developments in drug policies could resonate well with her area of expertise.
It is important to note that Ashleigh also covers international relations and conflicts such as the Middle East conflict and Russia-Ukraine conflict. Therefore, if your pitch relates to any evolving stories within these areas or includes relevant data citations from reputable sources, it might catch her attention.
Additionally, considering Ashleigh's frequent reference to government announcements and legal policy regulations in her coverage attributes suggests that she would likely appreciate pitches offering analysis or expert commentary on new legislative measures impacting the sectors she covers.
This information evolves through artificial intelligence and human feedback. Improve this profile .